WASHINGTON (Reuters) – Philip Morris International Inc should not be allowed to claim that its iQOS electronic tobacco device can reduce the risk of tobacco-related diseases compared with cigarettes, an advisory panel to the U.S. Food and Drug Administration said on Thursday.
Latest posts by Reuters News (see all)
- Search operation ended in Genoa, bridge death toll rises to 43 - August 19, 2018
- Italy to launch infrastructure plan in September: official - August 19, 2018
- Iran says U.S. ‘action group’ will fail to overthrow Iranian state - August 19, 2018